Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
Pre-market:
Sep 22, 2026, 4:25 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -24.28M | -3.73M | -40.11M | -25.56M | -69.84M | -29.95M | -26.15M | -172.03M | -7.59M | -12.08M | -105.96M | -6.46M | -11.94M | -67K | 87.43M | 99.65M | 156.72M | 146.86M | 126.24M | 53.96M | 49.14M | 75.47M |
Depreciation & Amortization | 10.18M | 12.98M | 4.42M | 15.84M | 15.39M | 14.91M | 15.18M | 14.04M | 14.55M | 13.75M | 12.98M | 13.1M | 11.8M | 10.91M | 10.03M | 9.91M | 8.91M | 9.26M | 3.44M | 8M | 7.79M | 6.3M |
Stock-Based Compensation | 16.95M | n/a | n/a | 9.06M | 6.79M | 10.4M | 10.55M | 13.05M | 13.76M | 12.06M | n/a | 9.99M | 9.27M | n/a | 6M | 4.74M | 4.31M | 3.63M | 2.23M | n/a | n/a | 2.28M |
Other Working Capital | 4.11M | -4.11M | -14.05M | 520K | -4.25M | -4.41M | -1.79M | -170K | -1.06M | -25.66M | 11.69M | 4.87M | 1.41M | -10.45M | -5.79M | -9.06M | -6.67M | -9.17M | -56.6M | -42.32M | -17.96M | 28.4M |
Other Non-Cash Items | -4.68M | 5.25M | 32.35M | -21.48M | 36.26M | -10.25M | -1.41M | 158.64M | -5.53M | -11.56M | -666.36M | -5.5M | -5.73M | 7.41M | 4.63M | -3.52M | -7.39M | -2.42M | 13.1M | 68.24M | 88.6M | -3.15M |
Deferred Income Tax | n/a | n/a | 6K | n/a | n/a | n/a | n/a | -2.44M | n/a | n/a | 764.75M | -5.53M | -2.76M | -1.52M | 7.01M | 9.23M | 12.86M | 13.22M | 17.47M | 11.23M | 6.45M | 11.76M |
Change in Working Capital | 5.83M | -5.83M | -19.43M | 6.99M | 1.14M | 5.49M | -12.81M | 1.87M | 2.24M | -10.64M | 2.38M | 8.57M | 18.55M | 68.34M | -15.76M | -9.96M | -11.13M | -8.24M | -104.32M | -35.87M | 13.96M | -54.32M |
Operating Cash Flow | 3.99M | 8.67M | -22.77M | -15.15M | -10.27M | -9.39M | -14.64M | 13.14M | 17.43M | -8.47M | 7.79M | 14.17M | 19.19M | 85.07M | 99.34M | 110.06M | 164.28M | 162.3M | 58.17M | 105.56M | 165.94M | 38.33M |
Capital Expenditures | -370K | -4.44M | -2.11M | -2.93M | -2.87M | -5.24M | -5.85M | -9.59M | -9.55M | -5.67M | -16.8M | -15.83M | -25.06M | -7.87M | -6.21M | -6.47M | -1.66M | -2.75M | -5.66M | -1.33M | -4.53M | -3.33M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -362K | -18.63M | n/a | n/a | n/a | n/a | n/a | n/a | 109K | -69.73M | -133K | 620K | n/a | -238.84M | n/a | 119.96M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 734K | 918K | -368K | 3.37M | 1.42M | 3.9M | 307K | 793K | 7.87M | -12.17M | n/a | n/a | n/a | n/a | n/a | n/a | 548K |
Investing Cash Flow | -370K | -4.44M | -2.11M | -2.93M | -3.24M | -23.13M | -4.93M | -8.96M | -6.18M | -4.24M | -12.9M | -15.52M | -24.16M | -69.73M | -18.52M | -5.85M | -1.66M | -241.58M | -5.66M | 118.63M | -4.53M | -2.78M |
Debt Repayment | n/a | -51.36M | -790K | -1.56M | -1.73M | -1.54M | -230.49M | -1.52M | -1.51M | -1.51M | -1.5M | -1.48M | -1.43M | -1.36M | -1.36M | -1.36M | -1.36M | -1.36M | -918K | -1.5M | -1.5M | -1.5M |
Common Stock Repurchased | n/a | n/a | n/a | 111K | n/a | n/a | -602K | n/a | -28K | -1.43M | n/a | n/a | n/a | -333K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -98.98M | -3.87M | -1.03M | -6.8M | 183K | 1.38M | -5.09M | 2.33M | 1.76M | 2.38M | 1.99M | 2.27M | -41.71M | -17.52M | -64.76M | -36.08M | -42.05M | -39.16M | -48.46M | -50.1M | -33.08M | -22.56M |
Financial Cash Flow | -98.98M | -55.23M | -1.82M | -8.25M | -1.53M | -4.9M | -236.19M | 809K | 228K | -560K | 470K | 783K | -43.13M | -19.21M | -66.12M | -37.44M | -43.41M | -40.52M | -49M | -51.28M | -34.13M | -24.06M |
Net Cash Flow | -95.34M | -50.97M | -26.68M | -26.33M | -15.15M | -37.35M | -255.76M | 4.99M | 11.48M | -13.27M | -4.64M | -571K | -48.1M | -3.87M | 14.69M | 66.77M | 119.21M | -119.8M | 3.37M | 173.19M | 127.04M | 11.49M |
Free Cash Flow | 3.62M | 4.23M | -24.88M | -18.08M | -13.14M | -14.63M | -20.49M | 3.55M | 7.88M | -14.13M | -9.01M | -1.66M | -5.87M | 77.21M | 93.12M | 103.59M | 162.62M | 159.56M | 52.51M | 104.23M | 161.41M | 34.99M |
Adj. Free Cash Flow | -13.33M | 4.23M | -24.88M | -27.13M | -19.93M | -25.03M | -31.03M | -9.51M | -5.88M | -26.19M | -9.01M | -11.65M | -15.14M | 77.21M | 87.13M | 98.85M | 158.31M | 155.93M | 50.28M | 104.23M | 161.41M | 32.72M |
Maintenance CapEx | -370K | -4.44M | -2.11M | -2.93M | -2.87M | -5.24M | -5.85M | -9.59M | -8.12M | -5.67M | -16.8M | -15.83M | -25.06M | -7.87M | -6.21M | -6.47M | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.66M | -2.75M | -5.66M | -1.33M | -4.53M | -3.33M |
Owner Earnings | 3.62M | 4.23M | -24.88M | -18.08M | -13.14M | -14.63M | -20.49M | 3.55M | 9.32M | -14.13M | -9.01M | -1.66M | -5.87M | 77.21M | 93.12M | 103.59M | 164.28M | 162.3M | 58.17M | 105.56M | 165.94M | 38.33M |
Add to Watchlist
Select watchlists to add or remove MRVI